Plague bacteria take refuge in amoebae

April 28, 2017, American Society for Microbiology
A scanning electron microscope micrograph depicting a mass of Yersinia pestis bacteria in the foregut of an infected flea. Credit: Wikipedia

Yersinia pestis, the bacterium that causes bubonic plague, can survive within the ubiquitous soil protozoan, the amoeba, by producing proteins that protect against the latter microbe's digestion. The research is published April 28th in Applied and Environmental Microbiology, a journal of the American Society for Microbiology.

The research is important because plague is a re-emerging disease, according to the Centers for Disease Control and Prevention, with 95 percent of cases occurring in sub-Saharan Africa and Madagascar. Modern antibiotics are effective, but without prompt treatment, plague can cause serious illness, or death.

Y. pestis spreads from rodent to rodent, and sometimes to human, often via fleas It uses the protective niche of the amoeba to abide when conditions are unfavorable to its spread, that is, when rodents are scarce, said Viveka Vadyvaloo, PhD, Assistant Professor, Paul G. Allen School for Global Animal Health, Washington State University, Pullman.

Amoebae are similar to certain , the macrophages, in their ability to engulf bacteria, or other nourishing items of similar size.These are taken up within special compartments called vacuoles, which in both amoebae and humans are capable of digestion. (image: scanning electron micrograph of a mass of Yersinia pestis.)

"With this in mind, graduate student Javier Benavides-MontaƱo separately cultured three distinct Y. pestis strains that have been associated with human epidemics, with a common laboratory strain of the free-living soil amoeba, Acanthamoeba castellanii, in a medium that supports the latter's growth," said Vadyvaloo.

Benavides-MontaƱo then tested Y. pestis' ability to enter and survive within the amoeba. To do so, he killed any bacteria that were outside of the amoebae, and then gently lysed the latter, and then placed the lysed content on a medium that encourages Y. pestis to grow. They were able to culture Y. pestis only after the amoebae had been lysed.

The investigators also used electron microscopy to peer inside intact amoebae, and found Y. pestis within the vacuoles.

"To understand more about how Y. pestis might be surviving within amoebae we considered how Y. pestis survive in human macrophages," said Vadyvaloo. "Macrophages usually engulf bacterial pathogens and destroy them, but some bacterial pathogens are able to avoid being killed therein by producing proteins that block the digestion." Indeed, that is the key strategy for a number of human pathogens. Some such proteins are known. So the investigators used mutant Y. pestis that doesn't produce one of these proteins. Those mutants failed to survive within the amoebae.

Vadyvaloo said that amoebae's longstanding reputation as Trojan horses for led her to investigate the possibility that plague bacteria could abide within their vacuoles. The best known example of this phenomenon had been Legionnaires' Disease, a respiratory disease that was discovered in 1976 after an outbreak among attendees at a convention of the American Legion in Philadelphia.

"This study serves as a proof of principle that can support prolonged survival of Y. pestis in the environment," said Vadyvaloo. It may encourage a search for this interaction within areas of Colorado and New Mexico where plague is endemic. And that, she said, could enable prediction of potential disease re-emergence, thereby reducing spread to humans.

Explore further: How small genetic change in Yersinia pestis changed human history

Related Stories

Researchers develop new candidate vaccines against the plague

October 13, 2016

Researchers from The University of Texas Medical Branch at Galveston have developed new potential vaccines that protect animals against the bacteria that causes the deadly plague. These findings are detailed in NPJ Vaccines.

US approves new treatment for ancient plague

April 27, 2012

Hardly anyone succumbs to the bubonic plague these days, but US health authorities on Friday approved a new treatment for it and other forms of the potentially deadly bacterial infection.

Recommended for you


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.